During the past decade, The HEARing CRC conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The HEARing CRC" #1 collaborator was "Royal Victoria Eye and Ear Hospital" with 7 trials as a collaborator, "Cochlear" with 6 trials as a collaborator, "The Hearing Cooperative Research Centre" with 2 trials as a collaborator, "Attune Hearing" with 1 trials as a collaborator and "Royal Prince Alfred Hospital, Sydney, Australia" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "The HEARing CRC" are "Hearing Loss" (8 trials) and "Tinnitus" (1 trials). Many other conditions were trialed in "The HEARing CRC" in a lesser frequency.

Most popular intervention types in "The HEARing CRC" are "Device" (9 trials). Other intervention types were less common.

The name of intervention was led by "Nucleus CI532 cochlear implant" (2 trials), "CS19 (1.6.2)" (1 trials), "Cochlear implant" (1 trials), "Cochlear implant with in-situ audiometry" (1 trials) and "Contour Advance electrode" (1 trials). Other intervention names were less common.

The vast majority of trials in "The HEARing CRC" are 9 trials for "All" genders.

Currently, there are NaN active trials in "The HEARing CRC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in The HEARing CRC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The HEARing CRC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".